Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATReceivables - Other
Ratios

Lipocine (LPCN) Other Gross PP&E Adjustments (2016 - 2024)

Lipocine (LPCN) has disclosed Other Gross PP&E Adjustments for 11 consecutive years, with $1.4 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other Gross PP&E Adjustments rose 6.94% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Dec 2024, up 6.94%, and an annual FY2024 reading of $1.4 million, up 6.94% over the prior year.
  • Other Gross PP&E Adjustments was $1.4 million for Q4 2024 at Lipocine, up from $1.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $1.4 million in Q4 2024 and bottomed at $1.1 million in Q4 2020.
  • Average Other Gross PP&E Adjustments over 5 years is $1.2 million, with a median of $1.3 million recorded in 2022.
  • The sharpest move saw Other Gross PP&E Adjustments changed 0.0% in 2020, then rose 11.62% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at $1.1 million in 2020, then grew by 5.4% to $1.2 million in 2021, then grew by 11.62% to $1.3 million in 2022, then rose by 1.02% to $1.3 million in 2023, then grew by 6.94% to $1.4 million in 2024.
  • Business Quant data shows Other Gross PP&E Adjustments for LPCN at $1.4 million in Q4 2024, $1.3 million in Q4 2023, and $1.3 million in Q4 2022.